Trial
NCT03393273
Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Multiple Myeloma
Intervention
Elotuzumab
Why stopped
Investigator decision in accordance with the promotor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-17